Vol 8, No 6 (December 01, 2017): Journal of Gastrointestinal Oncology

Original Article

A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients
Ramesh K. Ramanathan, Glen J. Weiss, Richard G. Posner, N.V. Rajeshkumar, Gayle Jameson, Meraj Aziz, Antje Hoering, Vanessa Bolejack, Anirban Maitra, Monica Fulk, Edward C. Stites, William S. Hlavacek, Zoran Gatalica, Joanne Xiu, Manuel Hidalgo, Daniel D. Von Hoff, Michael T. Barrett
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:925-935
.
A semi-automated assessment of sarcopenia using psoas area and density predicts outcomes after pancreaticoduodenectomy for pancreatic malignancy
Jukes P. Namm, Kiran H. Thakrar, Chi -Hsiung Wang, Susan J. Stocker, Malini D. Sur, onathan Berlin, William Dale, Mark S. Talamonti, Kevin K. Roggin
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:936-944
.
Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma
Andrea Bullock, Keith Stuart, Susanna Jacobus, Thomas Abrams, Raymond Wadlow, Michael Goldstein, Rebecca Miksad
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:945-952
.
Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins
Sarah J. Gao, Henry S. Park, Christopher D. Corso, Charles E. Rutter, Sajid A. Khan, Kimberly L. Johung
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:953-961
.
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer
Joseph Chao, James Lin, Paul Frankel, Andrew J. Clark, Devin T. Wiley, Edward Garmey, Marwan Fakih, Dean Lim, Vincent Chung, Eloise Luevanos, Scott Eliasof, Mark E. Davis, Yun Yen
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:962-969
.
Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm
Suparna C. Clasen, Bonnie Ky, Rupal O’Quinn, Bruce Giantonio, Ursina Teitelbaum, Joseph R. Carver
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:970-979
.
The correlations between serum amphiregulin and other clinicopathological factors in colorectal cancer
Chawalit Chayangsu, Siriporn Khunsri, Virote Sriuranpong, Suebpong Tanasanvimon
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:980-984
.
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer
Thomas Regenbogen, Ling Chen, Kathryn Trinkaus, Andrea Wang-Gillam, Benjamin R. Tan, Manik Amin, Katrina S. Pedersen, Haeseong Park, Rama Suresh, Kian-Huat Lim, Emily Ratchford, Amberly Brown, A. Craig Lockhart
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:985-989
.
Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma
Emma B. Holliday, Andrew Hunt, Y. Nancy You, George J. Chang, John M. Skibber, Miguel A. Rodriguez-Bigas, Brian K. Bednarski, Cathy Eng, Eugene J. Koay, Bruce D. Minsky, Cullen Taniguchi, Sunil Krishnan, Joseph M. Herman, Prajnan Das
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:990-997
.
Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base
Jaymin Jhaveri, Lael Rayfield, Yuan Liu, Mudit Chowdhary, Richard J. Cassidy, Nicholas A. Madden, Daniel G. Tanenbaum, Theresa W. Gillespie, Pretesh R. Patel, Kirtesh R. Patel, Jerome C. Landry
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:998-1008
.
Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography
Naruhiko Ikoma, Jeffrey H. Lee, Manoop S. Bhutani, William A. Ross, Brian Weston, Yi-Ju Chiang, Mariela A. Blum, Tara Sagebiel, Catherine E. Devine, Aurelio Matamoros Jr, Keith Fournier, Paul Mansfield, Jaffer A. Ajani, Brian D. Badgwell
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1009-1017
.
Tumor response evaluation after neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: a prospective, multi-center cohort study
Pietro Achilli, Paolo De Martini, Marco Ceresoli, Giulio M. Mari, Andrea Costanzi, Dario Maggioni, Raffaele Pugliese, Giovanni Ferrari
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1018-1025
.
Does histology really influence gastric cancer prognosis?
Carrie Luu, Ram Thapa, Katherine Woo, Domenico Coppola, Khaldoun Almhanna, Jose M. Pimiento, Dung-Tsa Chen, Daissy Dominguez Marquez, Pamela J. Hodul
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1026-1036
.
Characterization of malignant gastrointestinal stromal tumors—a single center experience
Matteo Mandrioli, Laura Mastrangelo, Michele Masetti, Nicola Zanini, Stefania Lega, Margherita Nannini, Elisa Gruppioni, Annalisa Altimari, Angelo Paolo Dei Tos, Carlo Fabbri, Elio Jovine
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1037-1045
.
HER-2/neu gene amplification in gastric adenocarcinoma and its relationship with clinical and pathological findings
Ramin Azarhoosh, Rokhsare Ebneghasem, Sima Besharat
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1046-1050
.
Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation
Maria M. Rubinstein, Andreas Kaubisch, Milan Kinkhabwala, John Reinus, Qiang Liu, Jennifer W. Chuy
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1051-1055
.
Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B-mode ultrasound—preliminary experience
Sasan Partovi, Ziang Lu, Rivka Kessner, Alice Yu, Yasmine Ahmed, Indravadan J. Patel, Dean A. Nakamoto, Nami Azar
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1056-1064
.
Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma
Yuchen Wang, Bashar M. Attar, Harry E. Fuentes, Palashkumar Jaiswal, Alfonso J. Tafur
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1065-1071
.
Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver
Kelly P. Orwat, Thomas H. Beckham, Samuel Lewis Cooper, Michael S. Ashenafi, Michael Bret Anderson, Marcelo Guimaraes, Ricardo Yamada, David T. Marshall
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1072-1078
.

Review Article

Safety of selective internal radiation therapy with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus
Andrew Kennedy, Daniel B. Brown, Jonas Feilchenfeldt, John Marshall, Harpreet Wasan, Marwan Fakih, Peter Gibbs, Alexander Knuth, Bruno Sangro, Michael C. Soulen, Gianfranco Pittari, Ricky A. Sharma
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1079-1099
.
Management of liver metastases from gastrointestinal stromal tumors: where do we stand?
Nikolaos Machairas, Anastasia Prodromidou, Ernesto Molmenti, Ioannis D. Kostakis, Georgios C. Sotiropoulos
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1100-1108
.

Short Communication

Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now
Zachary J. Brown, Jonathan M. Hernandez, R. Taylo Ripley, Jeremy L. Davis
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1109-1113
.

Letter to the Editor

Anal condylomas: predictors of recurrence and progression to high-grade dysplasia/carcinoma in situ
Armando Peixoto, Marco Silva, Rui Castro, Rosa Coelho, Alexandre Sarmento, Guilherme Macedo
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:1114-1115
.

Case Report

Probable paclitaxel-induced pancreatitis: uncommon case report and literature review
Hanan Raiss, Lamiae El Amarti, Jean Dominique Tigaud, Mohamed Layachi, Amandine Bruyas, Saber Boutayeb, Hassan Errihani
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:E80-E83
.
Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report
Moss Bruton Joe, Julian J. Lum, Peter H. Watson, R. Petter Tonseth, John Paul McGhie, Pauline T. Truong
Journal of Gastrointestinal Oncology  
2017;
8
(6)
:E84-E89
.